Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Health technology symbols : LIFE save search
aTyr Pharma to Participate in April Investor Conferences
Published: 2024-04-01 (Crawled : 12:00) - globenewswire.com
LIFE | $1.625 2.2% 2.15% 260K
|
Health Technology
|
| O: -1.01%
H: 0.0%
C: -3.05%
pharma
aTyr Pharma Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Update
Published: 2024-03-14 (Crawled : 20:00) - globenewswire.com
LIFE | $1.625 2.2% 2.15% 260K
|
Health Technology
|
| O: 0.0%
H: 24.07%
C: 22.84%
pharma year update results
aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2023 Financial Results
Published: 2024-02-28 (Crawled : 13:00) - globenewswire.com
LIFE | $1.625 2.2% 2.15% 260K
|
Health Technology
|
| O: 0.0%
H: 1.5%
C: -5.0%
pharma conference year financial results
aTyr Pharma Announces Expanded Access Program (EAP) for EFZO-FIT™ Clinical Trial Participants
Published: 2024-02-21 (Crawled : 13:00) - globenewswire.com
LIFE | $1.625 2.2% 2.15% 260K
|
Health Technology
|
| O: 1.6%
H: 5.24%
C: 3.14%
pharma program trial
aTyr Pharma to Present Posters Highlighting Importance of Neuropilin-2 in Immune Regulation at Keystone Symposia on Myeloid Cell Diversity
Published: 2024-01-29 (Crawled : 13:00) - globenewswire.com
LIFE | $1.625 2.2% 2.15% 260K
|
Health Technology
|
| O: 0.0%
H: 3.16%
C: 2.53%
pharma cell
aTyr Pharma Announces Howard University President Emeritus Dr. Wayne A. I. Frederick as Advisor
Published: 2024-01-18 (Crawled : 13:00) - globenewswire.com
WDAY S | $255.64 -0.54% -0.54% 1.3M
|
Technology Services
|
| O: 0.71%
H: 0.87%
C: 0.84%
PODD | $164.71 -0.93% -0.94% 590K
|
Health Technology
|
| O: 0.95%
H: 0.87%
C: 0.54%
LIFE | $1.625 2.2% 2.15% 260K
|
Health Technology
|
| O: 1.72%
H: 0.0%
C: -4.05%
pharma
aTyr Pharma Presents Poster Demonstrating Preclinical Effects of Efzofitimod in Rheumatoid Arthritis and Rheumatoid Arthritis-Associated ILD at the ACR Convergence 2023
Published: 2023-11-13 (Crawled : 13:00) - globenewswire.com
LIFE | $1.625 2.2% 2.15% 260K
|
Health Technology
|
| O: -1.79%
H: 6.36%
C: 1.36%
pharma preclinical efzofitimod
aTyr Pharma Announces Third Quarter 2023 Results and Provides Corporate Update
Published: 2023-11-09 (Crawled : 21:00) - globenewswire.com
LIFE | $1.625 2.2% 2.15% 260K
|
Health Technology
|
| O: 0.87%
H: 0.86%
C: -3.45%
pharma update results
Sarcoidosis Market to Register Incremental Growth During the Forecast Period (2023-2032), Asserts DelveInsight | Key Players - Pfizer, United Therapeutics, Xentria, aTyr Pharma, Kyorin Pharmaceutical, Novartis, Kinevant Sciences
Published: 2023-11-02 (Crawled : 21:00) - prnewswire.com
UTHR | $237.16 0.79% 0.78% 480K
|
Health Technology
|
| O: 0.73%
H: 0.63%
C: -2.35%
LIFE | $1.625 2.2% 2.15% 260K
|
Health Technology
|
| O: 0.78%
H: 1.54%
C: 0.0%
sciences growth market
aTyr Pharma to Present at November Investor Conferences
Published: 2023-11-01 (Crawled : 12:00) - globenewswire.com
LIFE | $1.625 2.2% 2.15% 260K
|
Health Technology
|
| O: 5.6%
H: 0.0%
C: -6.82%
pharma
aTyr Pharma Announces Dosing of First Patient in Phase 2 EFZO-CONNECT™ Study of Efzofitimod in Patients with SSc-ILDMultiple centers in the U.S. are open for enrollment
Published: 2023-10-31 (Crawled : 15:00) - biospace.com/
LIFE | $1.625 2.2% 2.15% 260K
|
Health Technology
|
| O: -0.8%
H: 2.42%
C: 0.81%
pharma efzofitimod study
aTyr Pharma Announces Dosing of First Patient in Phase 2 EFZO-CONNECT™ Study of Efzofitimod in Patients with SSc-ILD
Published: 2023-10-31 (Crawled : 12:00) - globenewswire.com
LIFE | $1.625 2.2% 2.15% 260K
|
Health Technology
|
| O: -0.8%
H: 2.42%
C: 0.81%
pharma efzofitimod study phase 2
aTyr Pharma Presents Efzofitimod Data Demonstrating Statistically Significant Improvements in Time to Relapse, FVC and Patient Reported Outcomes
Published: 2023-09-11 (Crawled : 12:00) - globenewswire.com
LIFE | $1.625 2.2% 2.15% 260K
|
Health Technology
|
| O: -1.2%
H: 2.44%
C: 1.22%
pharma efzofitimod
Lisa Carey
Published: 2023-08-24 (Crawled : 19:00) - atyrpharma.com
PSTX | News | $2.005 -1.72% -1.75% 520K
|
Health Technology
|
| O: 0.85%
H: 0.42%
C: -11.39%
LIFE | $1.625 2.2% 2.15% 260K
|
Health Technology
|
| O: 0.0%
H: 3.26%
C: 0.54%
ADXS | $0.6455 12.48% 2.3K
|
Health Technology
|
| O: 1.2%
H: 0.0%
C: -4.76%
aTyr Pharma to Present at the H.C. Wainwright 25th Annual Global Investment Conference
Published: 2023-08-24 (Crawled : 12:00) - globenewswire.com
LIFE | $1.625 2.2% 2.15% 260K
|
Health Technology
|
| O: 0.27%
H: 0.54%
C: 0.0%
pharma conference global
aTyr Pharma Announces Second Quarter 2023 Results and Provides Corporate Update
Published: 2023-08-09 (Crawled : 20:00) - globenewswire.com
LIFE | $1.625 2.2% 2.15% 260K
|
Health Technology
|
| O: 1.02%
H: 1.01%
C: -1.01%
pharma update results
Corporate Communications Intern
Published: 2023-08-08 (Crawled : 17:00) - atyrpharma.com
LIFE | $1.625 2.2% 2.15% 260K
|
Health Technology
|
| O: -0.51%
H: 1.28%
C: 0.0%
communications
Research Associate, In Vitro Biology
Published: 2023-06-22 (Crawled : 16:00) - atyrpharma.com
LIFE | $1.625 2.2% 2.15% 260K
|
Health Technology
|
| O: 1.3%
H: 0.39%
C: -2.99%
research in vitro
European Commission Grants Orphan Drug Designation for aTyr Pharma’s Efzofitimod for Treatment of Systemic Sclerosis
Published: 2023-06-22 (Crawled : 12:00) - globenewswire.com
LIFE | $1.625 2.2% 2.15% 260K
|
Health Technology
|
| O: 1.3%
H: 0.39%
C: -2.99%
drug sclerosis treatment designation grants efzofitimod
aTyr Pharma to Present on Lead Therapeutic Candidate Efzofitimod at the World Association for Sarcoidosis and Other Granulomatous Disorders (WASOG) Conference
Published: 2023-06-20 (Crawled : 12:00) - globenewswire.com
LIFE | $1.625 2.2% 2.15% 260K
|
Health Technology
|
| O: -0.41%
H: 0.0%
C: -4.51%
pharma candidate conference association efzofitimod
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.